We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Johnson and Johnson | NYSE:JNJ | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.16 | 0.11% | 151.38 | 152.21 | 150.70 | 151.85 | 6,827,226 | 21:15:01 |
From May 2019 to May 2024
Botox maker Allergan Inc. (AGN), subject of a nearly $46 billion offer from Valeant Pharmaceuticals International Inc. (VRX) and activist investor William Ackman, is soliciting interest from other potential suitors, including Sanofi (SNY) and Johnson & Johnson (JNJ), Bloomberg News reported Tuesday on its website, citing people with knowledge of the matter.
Allergen's talks with the two companies are at an early stage, Bloomberg reported, adding that it isn't clear if either Sanofi or Johnson & Johnson are interested in bidding.
Spokesmen for the three companies declined comment to Bloomberg.
Full story at: www.bloomberg.com/news/2014-04-29/allergan-said-to-explore-sale-to-sanofi-j-j-instead-of-valeant.html
Write to nymonitoring@dowjones.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
1 Year Johnson and Johnson Chart |
1 Month Johnson and Johnson Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
